David Klaaßen

2.9k total citations · 2 hit papers
37 papers, 2.1k citations indexed

About

David Klaaßen is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, David Klaaßen has authored 37 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 8 papers in Pathology and Forensic Medicine and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in David Klaaßen's work include Colorectal Cancer Treatments and Studies (6 papers), Cancer Treatment and Pharmacology (6 papers) and Genetic factors in colorectal cancer (4 papers). David Klaaßen is often cited by papers focused on Colorectal Cancer Treatments and Studies (6 papers), Cancer Treatment and Pharmacology (6 papers) and Genetic factors in colorectal cancer (4 papers). David Klaaßen collaborates with scholars based in Canada, United States and South Africa. David Klaaßen's co-authors include Charles G. Moertel, Richard G. Hahn, Stuart R. Lipsitz, Gordon E. Catton, C G Moertel, John Macintyre, P F Engstrom, Helen H. McDuffie, James A. Dosman and Robert A. Hickie and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Cancer.

In The Last Decade

David Klaaßen

34 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Streptozocin–Doxorubicin, Streptozocin–Fluorouracil, or Chlorozotocin in the Treatment of Advanced Islet-Cell Carcinoma

1992 658 citations Charles G. Moertel, Stuart R. Lipsitz et al. New England Journal of Medicine profile →
Treatment of locally unresectable cancer of the stomach and pancreas: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil--an Eastern Cooperative Oncology Group study.

1985 398 citations David Klaaßen, Gordon E. Catton et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by David Klaaßen

Since Specialization

Citations

This map shows the geographic impact of David Klaaßen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Klaaßen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Klaaßen more than expected).

Fields of papers citing papers by David Klaaßen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Klaaßen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Klaaßen. The network helps show where David Klaaßen may publish in the future.

Co-authorship network of co-authors of David Klaaßen

This figure shows the co-authorship network connecting the top 25 collaborators of David Klaaßen. A scholar is included among the top collaborators of David Klaaßen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Klaaßen. David Klaaßen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Morbidity and mortality associated with intraperitoneal chemotherapy for Pseudomyxoma peritonei 2002 ·The American Journal of Surgery ·Sonia A. Butterworth, O. Neely M. Panton, David Klaaßen, (unknown)	45
2	A National Cancer Institute of Canada Clinical Trials Group phase II study of eniluracil (776C85) and oral 5-fluorouracil in patients with advanced squamous cell head and neck cancer 2001 ·Annals of Oncology ·Meg Knowling, (unknown), Lillian L. Siu, K. Khoo, Andrew Cooke, Ian F. Tannock, David Klaaßen, (unknown), Glenwood Goss, S. Matthews, Robert B. Clarke, Lesley Seymour	3
3	Second primary malignancies following the treatment of early stage ovarian cancer: Update of a study by the National Cancer Institute of Canada—Clinical Trials Group (NCIC—CTG) 2000 ·Annals of Oncology ·Susan Dent, David Klaaßen, Joe Pater, Benny Zee, Marlo Whitehead	39
4	Streptozocin–Doxorubicin, Streptozocin–Fluorouracil, or Chlorozotocin in the Treatment of Advanced Islet-Cell Carcinoma breakdown → 1992 ·New England Journal of Medicine ·Charles G. Moertel, (unknown), Stuart R. Lipsitz, Richard G. Hahn, David Klaaßen	658
5	Men, women and primary lung cancer —A Saskatchewan personal interview study 1991 ·Journal of Clinical Epidemiology ·Helen H. McDuffie, David Klaaßen, James A. Dosman	17
6	Determinants of Cell Type in Patients with Cancer of the Lungs 1990 ·CHEST Journal ·Helen H. McDuffie, David Klaaßen, James A. Dosman	28
7	The Archival Intersection: Cooperation Between Collecting Repositories and Nonprofit Organizations 1990 ·David Klaaßen	2
8	Characteristics of Patients with Primary Lung Cancer Diagnosed at Age 50 Years or Younger 1989 ·CHEST Journal ·Helen H. McDuffie, David Klaaßen, James A. Dosman	26
9	Lower Prevalence of Positive Atopic Skin Tests in Lung Cancer Patients 1988 ·CHEST Journal ·Helen H. McDuffie, Donald W. Cockcroft, (unknown), David Klaaßen, James A. Dosman	20
10	Early stage ovarian cancer: a randomized clinical trial comparing whole abdominal radiotherapy, melphalan, and intraperitoneal chromic phosphate: a National Cancer Institute of Canada Clinical Trials Group report. 1988 ·Journal of Clinical Oncology ·David Klaaßen, Wendy Shelley, (unknown), (unknown), D. A. Boyes, (unknown), Martin Levitt, (unknown), J. Carmichael, (unknown)	65
11	The effects of continuing medical education on family doctor performance in office practice: a randomized control study 1988 ·Medical Education ·P. A. Jennett, (unknown), (unknown), David Klaaßen, Richard W. Swanson, Thomas W. Wilson, (unknown), (unknown), (unknown)	46
12	Achieving Balanced Documentation: Social Services from a Consumer Perspective 1986 ·David Klaaßen	1
13	A controlled evaluation of recent approaches to biochemical modulation or enhancement of 5-fluorouracil therapy in colorectal carcinoma. 1985 ·Journal of Clinical Oncology ·T Buroker, C G Moertel, Thomas R. Fleming, Lloyd K. Everson, Stephen A. Cullinan, James E. Krook, J A Mailliard, Robert F. Marschke, David Klaaßen, John A. Laurie	90
14	Combination chemo-radiotherapy for residual, recurrent or inoperable carcinoma of the rectum: E.C.O.G. study (EST 3276) 1985 ·International Journal of Radiation OncologyBiologyPhysics ·Cyril Danjoux, Richard D. Gelber, Gordon E. Catton, David Klaaßen	45
15	Inhibition of human breast cancer colony formation by anticalmodulin agents: Trifluoperazine, W-7, and W-13 1983 ·Cancer Chemotherapy and Pharmacology ·Jiann-Wu Wei, Robert A. Hickie, David Klaaßen	69
16	The Provenance of Social Work Case Records: Implications for Archival Appraisal and Access 1983 ·DigitalCommons - Kennesaw State University (Kennesaw State University) ·David Klaaßen	3
17	Survival and response to chemotherapy for advanced colorectal adenocarcinoma. An eastern cooperative oncology group report 1980 ·Cancer ·Philip T. Lavin, Arnold Mittelman, Harold O. Douglass, Paul F. Engstrom, David Klaaßen	85
18	Scientific Foundations of Oncology. 1977 ·Canadian Medical Association Journal ·David Klaaßen	1
19	Specific active immunochemotherapy in lung cancer: a survival study. 1977 ·PubMed ·T. H. M. Stewart, Ariel C. Hollinshead, James E. Harris, Shreya Raman, Richard E. Bélanger, (unknown), (unknown), (unknown), D. Craig Hooper, David Klaaßen, E Rapp, (unknown)	8
20	Acute leukemia long-term survival 1972 ·Cancer ·David Klaaßen, (unknown), (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact